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ABSTRACT 
 
There is accumulating evidence that membrane-bound 
receptors interact with many intracellular proteins. 
Multiprotein complexes associated with ionotropic receptors 
have been extensively characterized, but the identification of 
proteins interacting with G protein-coupled receptors (GPCRs) 
has so far only been achieved in a piecemeal fashion, focusing 
on one or two protein species. We describe a method based on 
peptide affinity chromatography, two-dimensional 
electrophoresis, mass spectrometry and immunoblotting to 
identify the components of multiprotein complexes interacting 
directly or indirectly with intracellular domains of GPCRs or, 
more generally, any other membrane-bound receptor. Using 
this global approach, we have characterized multiprotein 
complexes that bind to the carboxy-terminal tail of the 5-
hydroxytryptamine type 2C receptor and are important for its 
subcellular localization in CNS cells (Bécamel et al., EMBO J., 
21(10): 2332, 2002). 
 
 
INTRODUCTION 
 
Many cellular processes implicate large protein networks. The 
global identification of the components of these networks is 
essential to study their functions. There is accumulating 
evidence that membrane-bound receptors such as ionotropic 
receptors or tyrosine kinases are associated with large 
multiprotein complexes (1,2). G-protein coupled receptors 
(GPCRs), which constitute one of the largest known categories 
of proteins, also interact with several intracellular proteins in 
addition to G proteins (3-5). These proteins are important for 
some of the GPCR functions that do not implicate G-proteins 
(targeting, clustering, desensitization and resensitization, 
signaling not mediated by G-proteins) (6). Although proteins 
interacting with the intracellular loops of GPCRs have already 
been described, most of the proteins identified as binding 
partners of GPCRs associate with their cytosolic carboxy (C)-
terminal tail (5). Many GPCRs express a PDZ 
(PSD95/DiscLarge/ZO-1) domain recognition motif at their C-
terminal extremity (5,6). PDZ domains have emerged in the 
last few years as important modular protein interaction 
domains found in a new class of structurally related adaptor 
proteins (7). These proteins often form molecular scaffolds that 
link proteins into large signaling networks. This suggests that 
GPCRs can interact with multiprotein complexes, organized 
around PDZ domain based scaffolds, via  their C-terminal 
extremity. 
 
Several studies, often based on two-hybrid screens, have 
focused on the identification of proteins interacting with the C-
terminal tail of a particular GPCR (8-10). However, this 
approach provides the identification of only one or two protein 
species that directly interact with the receptor. We have 
recently developed a proteomic approach, based on peptide 
affinity chromatography, associated with high resolution 2-
dimensional (2-D) electrophoresis, a combination of Matrix-
Assisted Laser Desorption Ionization-Time Of Flight Mass 
Spectrometry (MALDI-TOF MS) and tandem mass 
spectrometry (MS/MS), and immunoblotting, to identify 
multiprotein complexes interacting with the 5-
hydroxytryptamine type 2C (5-HT2C) receptor. This GPCR 
expresses a C-terminal PDZ ligand (SSV), suggesting that it Bécamel et al.   95 
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interacts with a PDZ-based multiprotein complex (11). Using 
this approach, we have identified 15 proteins that bind directly 
or indirectly to the C-terminal tail of the 5-HT2C receptor (12). 
These include synapse-enriched multi domain proteins 
containing one or several PDZ domains and proteins devoid of 
PDZ domains. This method, which provides a global 
characterization of multiprotein complexes, can thus be used 
for systematic identification of proteins interacting with the 
intracellular domains of membrane-bound receptors and of 
protein networks associated with any protein. 
 
MATERIALS AND METHODS 
 
Antibodies and Plasmids 
 
The rabbit polyclonal anti-Veli3 antibody was purchased from 
Zymed Laboratories (San Francisco, CA), mouse monoclonal 
anti-CASK and anti-Mint1 antibodies from Becton Dinckinson 
Biosciences. The Veli2 antibody was obtained by 
immunization of rabbits with a synthetic peptide derived from 
the Veli2 sequence (QHHSYSSLESRG) as previously 
described (13). This antibody recognized a single polypeptide 
around 24 kDa in Western blots of mouse brain extracts (12). 
Horseradish peroxidase-coupled donkey anti-rabbit and 
antimouse secondary antibodies were from Amersham 
Biosciences (Upsalla, Sweeden).  
 
The expression vectors encoding the wild type and mutated C-
terminal tail of the human 5-HT2C receptor (residues 368-458) 
fused to GST (pGEX2C90SSV and pGEX902CSSA, 
respectively) have been described elsewhere (14). 
 
Membrane preparations and GST pull-down 
 
Mice brains were homogenized with a polytron in 20 ml 
phosphate buffered saline (PBS) and centrifuged at 200 x g for 
5 min. Pellets were resuspended in ice-cold lysis buffer 
containing Tris-HCl (50 mM, pH 7.4), EDTA (1 mM), and a 
protease inhibitor cocktail (Roche), homogenized 20 times on 
ice with a glass-Teflon homogenizer and centrifuged at 10,000 
x g for 30 min. The membrane pellets were resuspended in 
CHAPS extraction buffer (Tris-HCl, 50 mM pH 7.4; EDTA, 
0.05 mM; CHAPS, 10 mM and protease inhibitors) for 3 h in 
rotation at 4°C. Then, samples were centrifuged for 1 h at 
10,000 x g and solubilized proteins (supernatants, 20 mg 
protein per condition) were incubated with immobilized GST-
fusion proteins overnight at 4°C. GST and GST-fusion proteins 
were expressed in Escherichia coli strain BL21 and 
immobilized (50 µg each) on glutathione-sepharose 4B beads 
(Amersham Biosciences). Samples were washed five times 
with 150 mM NaCl and eluted with 10 mM reduced 
glutathione. Samples were then precipitated with 10% ice-cold 
trichloroacetic acid (TCA) for 2 h and precipitates were 
washed three times with diethyl ether. 
 
Two-dimensional electrophoresis 
 
TCA precipitates were resuspended in 350 µl 
isoelectrofocusing medium containing urea (7M), thiourea (2 
M), CHAPS (4% w/v), ampholines (preblended, pI 3.5-9.5, 8 
mg/ml, Amersham Biosciences), dithiothreitol (DTT, 100 
mM), Tergitol NP7 (0.2% v/v, Sigma) and traces of 
bromophenol blue (15). Proteins were first separated according 
to their isoelectric point along linear immobilized pH-gradient 
(IPG) strips (pH 3-10, 18 cm long) using the IPGphor 
apparatus (Amersham Biosciences). Sample loading for the 
first dimension was performed by passive in-gel re-swelling. 
After the first dimension, the IPG strips were equilibrated for 
10 min in a buffer containing urea (6M), Tris-HCl (50 mM, pH 
6.8), glycerol  (30% v/v), SDS (2% w/v), DTT (10 mg/ml) and 
bromophenol blue and then for 15 min in the same buffer 
containing 15 mg/ml iodoacetamide instead of DTT. For the 
second dimension, the strips were loaded onto vertical 12.5% 
SDS polyacrylamide gels. The gels were silver stained 
according to the procedure of Shevchenko et al. (16). 
 
Image acquisition and 2-D gel spot pattern 
analysis 
 
Gels to be compared were always processed and stained in 
parallel. Gels were scanned using a computer-assisted 
densitometer (Amersham Biosciences). Spot detection, gel 
alignment and spot quantification were performed using the 
Image Master 2-D Elite software (Amersham Biosciences). 
Quantitative variations of proteins were expressed as volumes 
of spots. To correct for variability resulting from silver 
staining, results were expressed as relative volumes of all spots 
in each gel. Data are the means of values from four gels 
originating from different pull-down experiments. 
 
Protein identification by MALDI-TOF mass 
spectrometry 
 
Proteins of interest were excised and digested in gel using 
trypsin (sequencing grade, Promega, Madison, WI), as 
previously described (16,17). Digest products were completely 
dehydrated in a vacuum centrifuge and resuspended in 10 µl 
formic acid (2% v/v), desalted using Zip Tips C18  (Millipore, 
Bedford, MA), eluted with 10 µl acetonitrile:trifluoroacetic 
acid, (80:0.1%) and concentrated to 2 µl. Aliquots of analyte 
solutions were mixed with the same volume of α-cyano-4-
hydroxy-trans-cinnamic acid (10 mg/ml in 
acetonitrile:trifluoroacetic acid, 50:0.1%) and loaded on the 
target of a BIFLEX III MALDI-TOF mass spectrometer 
(Bruker-Franzen Analytik, Bremen, Germany) using the Dry-
droplet procedure (18). Analysis was performed in reflectron 
mode with an accelerating voltage of 20 kV and a delayed 
extraction of 400 ns. Mass spectra were acquired as the sum of 
the ion signals that were generated by irradiation of the target Bécamel et al.   96 
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with a mean of 300 laser pulses. Spectra were analyzed using 
the XTOF software (Bruker-Franzen Analytik) and 
autoproteolysis products of trypsin (m/z  842.51, 1045.56, 
2211.10) were used as internal calibrates. Peptides were 
selected in the mass range of 800-3500 Da. Identification of 
proteins was performed using both Mascot and PeptIdent 
softwares, available online at http://www.matrixscience.com 
and http://www.expasy.org/tools/peptident.html, respectively. 
A mass deviation of 100 ppm was allowed for data base 
interrogation, but the mass accuracy of our analyses was 
usually better than 50 ppm. Coverage of the full-length protein 
exceeding 15% was considered to be sufficient unless there 
were some obvious conflicts between the experimental 
molecular weight or isoelectric point and those of the identified 
protein (19). Matching peptides with missed cleavages were 
considered as pertinent only when there were two consecutive 
basic residues or when arginine and lysine residues were 
followed by a proline or acidic residues inside the peptide 
amino acid sequence. 
 
Protein identification by tandem mass 
spectrometry 
 
Nanoelectrospray mass spectrometry was performed on a 
quadrupole time-of-flight (Q-TOF) mass spectrometer 
(QSTAR; Sciex, Toronto, Canada) equipped with a nanospray 
source (Protana Inc., Odense, Denmark). The needle containing 
1  µl peptide mixtures, purified by using POROS R2 micro 
columns (Protana), was briefly touched against the interface 
plate and then centered in front of the mass spectrometer 
orifice. A potential of 900 V at the needle started the 
nanospray. Peptide fragmentation was performed in the 
collision cell using nitrogen gas on the doubly charged peptide 
ions detected, with a collision energy profile optimized 
individually for each peptide (30-55 V). Tandem mass spectra 
were interpreted using the BioAnalyst software (Applied 
BioSystems). Identification of proteins was performed by 
matching the experimental MS/MS spectra of multiple peptides 
from the same protein against calculated spectra for all 
peptides in a protein sequence database, using the Mascot 
software (http://www.matrixscience.com). For Mascot 
searches, a positive score was defined to be greater than 30 for 
each peptide ion. The identification was systematically 
confirmed by manual interpretation of the MS/MS spectra by 
the “peptide sequence tag” method using the BioAnalyst and 
PeptideSearch softwares (www.narrador.emblheidelberg.de) 
(20,21). 
 
Immunoblotting 
 
Proteins, resolved on 1-D or 2-D gels, were transferred 
electrophoretically onto nitrocellulose membranes (Hybond-C, 
Amersham Biosciences). Membranes were incubated overnight 
with primary antibodies. Immunoreactivity was detected with 
an enhanced chemiluminescence method (Renaissance Plus, 
NEN DuPont, Boston, MA). 
 
RESULTS AND DISCUSSION 
 
Proteins interacting with the cytosolic C-terminal tail of the 5-
HT2C  receptor were purified by peptide affinity 
chromatography using the entire C-terminal tail of the receptor 
(90 amino acids) fused to GST (GST902CSSV) as bait. The 
bait (50 µg per assay) was immobilized onto glutathione 
sepharose beads. Whole brain extracts were used in this 
purification step because the 5-HT2C receptor displays a wide 
and discrete distribution in the central nervous system. The 
bound proteins were eluted, separated by 2-D electrophoresis 
and stained with silver. For silver staining, we used a procedure 
allowing further micro characterization of proteins by mass 
spectrometry (16). This method omits the sensitization with 
glutaraldehyde, which is known to make covalent bounds with 
proteins through Schiff base formation with amino groups, and 
minimizes oxidation of proteins. Fig. 1 illustrates a typical 2-D 
gel obtained with the GST902CSSV bait. These gels exhibited 
numerous protein spots, probably due to the high sensitivity of 
the silver staining procedure used, which detects proteins in the 
nanogramme range (Fig. 1). Among these proteins, several 
major spots were identified as GST and/or GST fusion protein 
by MALDI-TOF mass spectrometry (Fig. 1). 
 
 
Fig. 1: Protein 2-D map of multiprotein complexes interacting with the C-
terminal extremity of the 5-HT2C receptor. Proteins interacting with the C-
terminal tail of the 5-HT2C receptor were purified by peptide affinity 
chromatography on glutathione sepharose beads using the C-terminal 90 amino 
acid residues of the receptor (GST902CSSV) as bait. Proteins, recovered with 
reduced glutathione, were resolved on 2-D gels and stained with silver. A 
representative gel is illustrated. Arrows and arrowheads indicate protein spots 
that were not detectable (or much less represented) in gels obtained using the 
GST902CSSA and GST baits, respectively. The unlabelled spots were found in 
equal amounts in gels performed with all baits. Some of them were identified 
as  E. coli proteins or major brain proteins. MALDI-TOF MS and MS/MS 
analyses of Veli3 (red) and Dlgh3 (blue) are described in detail on Figures 2 
and 3, respectively. 
 
To detect proteins that specifically interact with the C-terminal Bécamel et al.   97 
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tail of the 5-HT2C receptor, we performed differential analyses 
of 2-D gel protein patterns obtained with the GST902CSSV 
bait and two control baits: 1) GST alone and 2) GST fused to 
the C-terminal tail of the 5-HT2C receptor which was mutated 
on the C-terminal residue of the PDZ ligand (GST902CSSA). 
This residue is critical for the interaction with target PDZ 
domains (14). A comparison of protein patterns in the 2-D gels 
obtained with the GST902CSSV and GST902CSSA baits, 
indicated a selective recruitment of 5 spots or groups of spots 
(indicated by arrows in Fig. 1) by the wild type bait. These 
spots were not detectable on gels performed with the 
GST902CSSA bait (n = 4 gels originating from 4 pull-down 
experiments, see Figs. 2 and 3). These proteins were 
unambiguously identified by MALDI-TOF and/or MS/MS as 
four distinct proteins (Figs. 1-3). Three of them are proteins 
that contain one or several PDZ domains. The fourth protein 
that bound selectively to the wild type bait (dynamin 1) was 
devoid of PDZ domains, but its association with proteins 
containing PDZ domains has already been suggested. This 
protein may thus be indirectly recruited by the C-terminal tail 
of the 5-HT2C receptor through a PDZ domain-based scaffold. 
Altogether, these results validate the method used to purify and 
detect proteins interacting specifically with PDZ domain 
recognition motifs located at the C-terminal extremity of 
membrane-bound receptors. 
 
 
Fig. 2: MALDI-TOF mass spectrometry identification of Veli3 as a 
binding partner of the PDZ ligand of the 5-HT2C receptor. A. Areas of 
interest of silver-stained 2-D gels obtained in experiments using the 
GST902CSSV, GST902CSSA and GST baits, respectively, and showing the 
specific recruitment of one protein spot by the PDZ ligand of the 5-HT2C 
receptor.  B.  MALDI-TOF peptide mass map obtained from in-gel trypsin 
digestion of this spot. Ion signals with measured masses that matched 
calculated masses of protonated tryptic peptides of mouse Veli3 are indicated. 
T indicates the ion signals corresponding to the autolysis products of trypsin 
that were used for internal calibration of spectra (mol wt: 842.51, 1045.56 and 
2211.10, respectively). 
 
Fig 2C: Parameters and results of SwissProt and Trembl database search. 
 
We also detected an enrichment of several protein species in 2-
D gels obtained in pull down experiments performed with the 
GST902CSSV and GST902CSSA baits, when compared with 
those obtained with GST alone (four gels performed in each 
experimental condition). These proteins are indicated by 
arrowheads on Fig. 1. Identical amounts of these proteins were 
retained by the wild type and mutated baits. These proteins that 
include cytoskeleton proteins as well as signaling proteins, lack 
obvious PDZ domains. This indicates that they interact with 
residues that are not located in the PDZ ligand of the receptor. 
The data illustrated in Fig. 1 demonstrate that the resolution 
provided by 2-D gel electrophoresis combined with the high 
sensitivity of the silver staining procedure was required to 
detect the proteins specifically recruited by the 5-HT2C receptor 
C-terminal tail. As previously mentioned, the 2-D protein 
pattern recovered from the GST pull down assays exhibited 
numerous protein spots. Some of these spots were identified as 
either bacterial proteins that bind to GST and/or fusion peptide 
during bait production in bacteria, or major proteins from mice 
brain. The gels also showed a large enrichment of GST baits, 
compared with most of the proteins identified as specific 
binding partners of the receptor. Separating proteins by 1-D 
electrophoresis would have probably precluded the detection of 
proteins with a molecular weight similar to that of the bait, 
such as the Veli3 protein (Figs. 1 and 2). Moreover, 
identification of proteins by MALDI-TOF mass spectrometry, 
which only provides peptide mass fingerprints but not sequence 
information, requires an efficient purification procedure such 
as that provided by 2-D electrophoresis.  
 
However, GST proteins or any other contaminating protein 
may mask specific binding partners of the receptor, even when 
proteins are separated by 2-D electrophoresis. Moreover, 
several limitations inherent to 2-D electrophoresis make 
difficult the detection and the identification of some of the 
proteins purified during the affinity chromatography step such 
as hydrophobic, basic (pI > 9), large (> 200 kDa) and small (< 
10 kDa) proteins. An alternative approach, that combines 
efficient separation of biological materials and high sensitivity, 
associates 1-D electrophoresis and liquid chromatography (LC) 
coupled to MS/MS (LC-MS/MS) (21). This approach, based on Bécamel et al.   98 
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LC separation of tryptic peptides prior to MS/MS, can 
theoretically analyze complicated mixtures containing up to 
hundreds of proteins (21), and has already been used to identify 
proteins physically associated to the N-methyl-D-aspartate 
receptor and separated by 1-D electrophoresis (1). This 
methodology largely removes the difficulty to identify proteins 
containing several trans-membrane domains and basic proteins. 
A procedure which do not require any gel separation and 
staining and based on direct trypsin digestion of proteins 
purified by affinity chromatography followed by LC-MS/MS 
analysis, would also resolve the issue of identifying large 
proteins as well as peptides that bind to the C-terminal tail of 
the receptors. This strategy has been successfully used by 
Ficarro et al. (22) to characterize the yeast phosphoproteome 
purified by affinity chromatography. However, the large 
variations in protein concentration in our samples (e.g. GST 
bait and Veli3) may render uncertain the identification of 
minor proteins by these alternative approaches. Moreover, our 
strategy based on 2-D gels remains a method of choice to 
perform differential analyses of protein expression. 
 
In our experience, MALDI-TOF mass spectrometry yielded 
non-ambiguous identification of most of the proteins examined. 
Mean sequence coverage of 40% was obtained, which is a 
much higher score than that generally admitted (15-20% of 
protein coverage) (19). Moreover, the identity of the protein 
was always confirmed in 2-D immunoblotting when antibodies 
against the identified proteins were available. The high success 
rate in these analyses was linked to the high mass accuracy 
achieved. Indeed, the deviation between experimental peptide 
masses and those resulting from theoretical digestion of the 
protein was generally inferior to 50 ppm using trypsin autolysis 
peptides as internal calibrates. Another important characteristic 
of the MALDI-TOF technology is its ability to discriminate 
between closely related proteins, even when these proteins 
share high degrees of identity. Veli3, one of the proteins that 
was recruited by the C-terminal tail of the 5-HT2C receptor, 
belongs to a family of related proteins containing one PDZ 
domain and named Veli1, Veli 2 and Veli3 (for Vertebrate 
homologues of LIN-7) (23). Veli3 and Veli2 amino acid 
sequences show 81% identity. Moreover, both proteins display 
similar molecular weights and isoelectric points, indicating a 
possible overlap of both proteins on 2-D gels. The peptide 
masses deduced from the MALDI-TOF mass spectrum 
illustrated in Figure 2B only matched the theoretical peptide 
masses calculated for Veli3 according to the criteria defined in 
“Materials and Methods.” Eight tryptic peptides, corresponding 
to the coverage of almost 50% of the sequence, were assigned 
to the sequence (Figure 2C). The second ranked protein was 
Veli2, but only 3 peptides corresponding to 14% sequence 
coverage were assigned to the sequence. This specific 
identification of Veli3 versus Veli2 as a binding partner of the 
5-HT2C receptor was further confirmed by immunoblotting 
using specific antibodies raised against both proteins (data not 
shown). 
 
The identity of several proteins recruited in our in vitro binding 
assay was confirmed by MS/MS. Because MS/MS spectra 
contain sequence information on the peptides rather than only 
their mass, this approach is certainly more discriminating. 
MS/MS analysis was systematically performed when no 
antibody against the protein of interest was available. It is 
noteworthy that in our analyses MS/MS data always confirmed 
the results obtained by MALDI-TOF MS. Two methods that 
generally provided identical results were used to identify 
proteins by MS/MS: 1) the match of the experimental 
fragmentation spectrum against the theoretical spectra of all 
peptides in protein databanks and 2) the sequence tag method. 
Peptide sequence tag combines a short sequence stretch with 
mass information that specifies the location of the identified 
sequence inside the tryptic peptide (21). These two approaches 
generally yielded identical results. Fig. 3 illustrates the MS/MS 
analysis of one of the double charged tryptic peptides (m/z = 
645.83) of Dlgh3, a protein that was identified as one of the 
binding partners of the PDZ ligand of the 5-HT2C receptor by 
MALDI-TOF MS. Comparing the experimental fragmentation 
spectrum (Fig. 3B) with a calculated spectrum for all peptides 
in the NCBI database yielded a single match with a high score 
and corresponding to a Dlgh3 peptide (Fig. 3C). We obtained 
the same unique peptide match by the peptide sequence tag 
(determined by interpretation of the MS/MS spectrum with the 
BioAnalyst software) method and Non-Redundant Protein 
Database interrogation using the PeptideSearch algorithm (Fig. 
3D). 
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Fig. 3: Tandem mass spectrometry identification of Dlgh3 as a binding 
partner of the PDZ ligand of the 5-HT2C receptor. A. Areas of interest of 
silver-stained 2-D gels obtained in experiments using the GST902CSSV, 
GST902CSSA and GST baits, respectively, and showing the specific 
recruitment of four protein spots (indicated by arrows) by the PDZ ligand of 
the 5-HT2C receptor. These spots were identified as a single protein by 
MALDI-TOF MS (not shown). B. Fragmentation spectrum of a double charged 
ion at m/z = 645.80 detected on the nanoelectrospray mass spectrum of the 
tryptic digestion product of one of these spots. A sequence of five amino acids 
is apparent in the higher mass part of the spectrum. C. Graphical representation 
of hits obtained by matching the fragmentation spectrum illustrated in B. and 
the calculated spectra of all the peptides in the NCBr database. D. Parameters 
and results of Non-Redundant Database search using the peptide sequence tag 
method. Both methods yielded a single match with a mouse Dlgh3 peptide. 
 
Our procedure using silver staining of 2-D gels allows the 
detection of proteins recruited in relatively low amounts (a few 
ng) in the affinity chromatography step. The sensitivity of 
silver staining allows full use of the sensitivity of current 
MALDI-TOF and Quadrupole-TOF mass spectrometers like 
those used in our study. In this regard, the intensities of ion 
signals detected by MALDI-TOF mass spectrometry in digests 
of small protein spots (such as those identified as Dlgh3) were 
in the same range as those obtained with a mixture of external 
peptide calibrates (50-100 fmol each). However, the low 
dynamic range and the rapid saturation of silver staining only 
allow semi-quantitative measurements of proteins detected on 
2-D gels. Other staining procedures using fluorescent dyes   
(e.g. Sypro Ruby), that are just as sensitive as silver staining, 
would certainly provide more quantitative information without 
precluding further identification of proteins by mass 
spectrometry. 
 
Despite the reasonably high sensitivity of silver staining, we 
failed to detect some of the binding partners of the receptor, in 
particular those that indirectly interact with its C-terminal 
extremity. This critical limitation for a global characterization 
of multiprotein complexes cannot be overcome by increasing 
the amount of proteins loaded on the 2-D gels. Indeed, due the 
high amount of GST baits in the samples, compared with the 
other proteins, overloading the gels would alter the 
electrofocusing of proteins during the first dimension. To 
identify additional protein components of the complexes 
purified by affinity chromatography, we combined mass 
spectrometry with immunoblotting screens. These 
immunoblotting screens were based on the data of the literature 
on the known partners of the proteins previously identified by 
mass spectrometry analyzes. For example, the Veli proteins are 
known to be part of ternary protein complexes also composed 
of CASK, a membrane-associated guanylate kinase that 
contains one PDZ domain, and Mint1, a modular protein that 
contains two PDZ domains (24,25). Immunoblotting 
experiments performed with a CASK and a Mint1 antibody 
after the affinity chromatography step showed that both CASK 
and Mint1 were recruited by the C-terminal extremity of the 5-
HT2C receptor (12). This suggests that the 5-HT2C receptor 
interacts with the entire ternary complex Veli3-CASK-Mint1. 
CASK is known to interact with both Veli proteins and Mint1. 
These interactions do not involve PDZ domains, which are free 
to interact with additional protein partners (24). Several pieces 
of evidence indicate that the ternary complex Veli3-CASK-
Mint1 interacts with the 5-HT2C receptor through Veli3 and, 
thus, that CASK and Mint1 are indirect partners. 1) Only Veli3 
was detected by silver staining, indicating that lower amounts 
of CASK and Mint1 were recruited. 2) Veli3 and the 5-HT2C 
receptor interacted in heterologous cells (12). 3) The PDZ 
domain of Veli3 is class I, which determines optimal binding to 
the PDZ ligand of the 5-HT2C receptor. In contrast, the PDZ 
domain of CASK is class II, which renders improbable its 
direct binding to the PDZ ligand of the 5-HT2C receptor (7). 
This example illustrates how immunoblotting associated with 
mass spectrometry may be useful to detect low amounts of 
proteins in a complex such as proteins indirectly associated 
with a receptor. 
 
One important issue concerns the specificity of the protein 
complexes identified by our fishing approach. Co-
immunoprecipitation experiments performed with some of the 
binding partners of the 5-HT2C receptor indicated for all the 
proteins tested that the receptor interacts with them in the 
mouse CNS (12). Moreover, immunohistochemistry and 
electron microscopy experiments revealed a similar distribution 
of these proteins and the 5-HT2C receptor in CNS cells. Finally, 
we have used a similar approach to identify the protein 
complexes interacting with the C-terminal extremities of three 
other 5-HT receptors that express PDZ-like ligands (namely the 
5-HT2A receptor and two splice variants of the 5-HT4 receptor). 
The four complexes examined showed different protein 
composition (unpublished results). 
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CONCLUSIONS 
 
We have established a specific and sensitive method to purify 
and identify the proteins that interact directly or indirectly with 
the C-terminal extremity of GPCRs. This approach may be 
used to characterize the multiprotein complexes interacting 
with the intracellular domains of any membrane-bound 
receptors and, more generally, the protein complexes 
associated with any intracellular protein. 
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PROTOCOLS 
 
Production and immobilization of GST fusion proteins 
 
Solutions and media: 
 
•  SOC medium: 2% tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2 and 20 mM glucose 
•  SOB-ampicillin medium: 2% tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2 and 100 µg/ml 
ampicillin 
•  LB-ampicillin plate: 1% tryptone, 0.5% yeast extract, 1% NaCl, 10 mM MgCl2, 100 µg/ml ampicillin and 1.3% agar 
•  Cell lysis solution: phosphate buffered saline (PBS), 0.5 mM DTT and a protease inhibitor cocktail (Roche) 
 
Protocol: 
 
1.  Transfer 1 ng of plasmid DNA in 25 µl of BL21 competent cell suspension. Stir gently to mix. Incubate successively at 0°C 
for 30 min, at 42°C for 30 sec and then at 0°C for 2 min 
2. Add  500  µl of SOC medium. Incubate at 37°C for 1 h with shaking 
3. Plate  200  µl of BL21 cell suspension on LB-ampicillin. Incubate overnight at 37°C 
4.  Remove a single colony and culture in 50 ml of SOB-ampicillin medium overnight at 37°C 
5.  Add 450 ml of SOB-ampicillin medium and culture at 37°C until OD600nm = 0.5 
6.  Induce synthesis of recombinant proteins by adding 0.25 mM isopropyl-ß-D-thiogalactopyranoside for 3 h at 37°C 
7.  Harvest cells by centrifugation at 1,000 x g for 15 min at 4°C 
8.  Suspend completely the cell pellet in 25 ml cell lysis solution and sonicate on ice 5 times for 1 min 
9.  Add 1% Triton X100 and leave samples in rotation at 4°C for 1 h 
10.  Centrifuge at 12,000 x g for 10 min at 4°C. Keep the surpernatant. The amount of recombinant protein can be estimated by 
SDS-PAGE of an aliquot using bovine serum albumin as standard. 
11. Incubate  50  µg of each GST-fusion protein with 500 µl of glutathione Sepharose beads for 1 h in rotation at 4°C 
12.  Wash beads 3 times with PBS 
 
Preparation of CHAPS-soluble brain extracts 
 
Solutions: 
 
•  Lysis buffer: 50 mM Tris-HCl, pH 7.4, 1 mM EDTA and the protease inhibitor cocktail 
•  Solubilization buffer: 50 mM Tris-HCl, pH 7.4, 0.05 mM EDTA, 10 mM CHAPS and the protease inhibitor cocktail 
 
Protocol: 
 
1.  Dissect 2 mice brains per condition and homogenize with a polytron in 10 ml PBS. Centrifuge at 200 x g for 5 min 
2.  Suspend the pellet in 2 ml ice-cold lysis buffer/2 mice brains and homogenize 20 times on ice with a glass-Teflon 
homogenizer. Centrifuge at 10,000 x g for 30 min at 4°C 
3.  Suspend membrane pellet in 2 ml solubilization buffer and homogenize 5 times on ice with a glass-Teflon homogenizer. Leave 
samples on rotation for 3 h at 4°C 
4.  Centrifuge at 10,000 x g for 1 h at 4°C. Keep the supernatant (solubilized proteins) 
 
GST pull-down 
 
1.  Incubate solubilized proteins of 2 mice brains with immobilized GST fusion proteins overnight in rotation at 4°C 
2.  Wash beads 5 times with 0.5 M NaCl 
3.  Incubate beads with 10 mM reduced glutathione for 1 h in rotation at 4°C 
4.  Centrifuge at 1,000 x g for 10 min at 4°C. Keep the supernatant 
5.  Precipitate proteins with 10% ice-cold TCA for 2 h on ice 
6.  Centrifuge at 10,000 x g for 15 min at 4°C 
7.  Wash the TCA precipitates 3 times with 1 ml diethyl ether Bécamel et al.   102 
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Two-dimensional electrophoresis 
 
Materials: 
 
First dimension: IPGPhor + strip holders (18 cm long, Amersham Biosciences) 
Second dimension: Etan-Dalt II (Amersham Biosciences) 
 
Solutions: 
 
•  Isoelectrofocusing medium: 7 M urea, 2 M thiourea, 4% CHAPS, ampholines (preblended, pI 3.5-9.5, 8 mg/ml), 100 mM 
DTT, 0.2% Tergitol NP7 and traces of bromophenol blue 
•  Equilibration medium with DTT: 50 mM Tris-HCl, pH 6.8, 30% glycerol, 2% SDS, 10 mg/ml DTT and traces of bromophenol 
blue 
•  Equilibation medium with iodoacetamide: 50 mM Tris-HCl, pH 8.8, 30% glycerol, 2% SDS, 15 mg/ml iodoacetamide and 
traces of bromophenol blue 
•  Polycrylamide gel mixture: 12.5% acrylamide (Plus One, Amersham Biosciences), 0.16% bisacrylamide (Plus One), 375 mM 
Tris-HCl, pH 8.8, 0.1% SDS, 0.015% ammonium persulfate and 0.05% TEMED 
•  Agarose solution: 1% agarose (low-melting), 150 mM Tris-HCl, pH 6.8, 0.2% SDS 
 
Protocol: 
 
1.  Suspend the TCA precipitates in 350 µl isoelectrofocusing medium. 
2.  Apply the sample between the electrodes of a strip holder. 
3.  Add a pre-casted IPG dry strip (pH 3-10, linear, 18 cm long, Amersham Biosciences). 
4.  Recover with 1 ml mineral oil. 
5.  Perform the isoelectrofocusing with the following parameters and steps: 20°C, 50 µA per strip, rehydration period, 12 h; 
gradient 0-300 V, 1 min; step-and-hold 300 V, 30 min; gradient 300-5000 V, 3 h; step-and-hold 5000 V, 40,000 V/h. The 
strips can be kept for several months at –80°C after isoelectrofocusing. 
6.  Incubate the strip for 10 min with 6 ml equilibration medium with DTT. 
7.  Remove the excess of DTT on the strip. 
8.  Incubate the strip for 15 min with 6 ml equilibration medium with iodoacetamide. 
9.  Load the strip on the top of a 12.5% polyacrylamide gel (20 x 20 cm, 1 mm thick). 
10.  Seal the strip with 1-2 ml agarose solution (heated at 60°C). 
11. Perform the second dimension in two steps: 1) 1 h at 60 V and 45 mA per gel (an initial low-voltage step reduces 
electroendosmosis); 2) 5 h at 300 V, 45 mA per gel. 
 
Silver staining 
 
1.  Fix the gel in ethanol:acetic acid (50:5% in distilled water) for 20 min. 
2.  Incubate the gel in 50% ethanol for 10 min. 
3.  Wash the gel with distilled water for 10 min. 
4.  Incubate the gel with sodium thiosulfate (0.02%) for 1 min. 
5.  Wash the gel for 10 sec twice with distilled water. 
6.  Stain the gel with AgNO3 (1 g/l) for 20 min at 4°C. 
7.  Wash the gel for 10 sec twice with distilled water. 
8.  Incubate the gel with the developing solution (40 g/l Na2CO3, 0.1% formaldehyde). Change rapidly the developing solution 
after a yellow precipitate appears and incubate the gel with the new solution until appropriate staining is achieved. 
9.  Stop the revelation by replacing the developing solution by 5% acetic acid. 
10.  Store the gel in 1% acetic acid at 4°C (the gels can be stored for a few weeks before digestion). 
 
Image acquisition and two-dimensional protein pattern analysis 
 
1.  Scan the gels with a computer-assisted densitometer (such as the ImageScanner, Amersham Biosciences, etc.). 
2.  Detect protein spots in the gels to be processed with a 2-D gel analysis software (such as Image Master 2D Elite, Amersham Bécamel et al.   103 
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Biosciences, etc.). 
3.  Suppress dark noise. 
4.  Match the corresponding spots in the gels to be processed and perform gel alignment. 
5.  Perform spot quantification (expressed as spot volume relative to either the volume of all spots in each gel or the volume of a 
single spot found in equal amount in all experimental conditions, to correct for variability resulting from silver staining). 
6.  Calculate mean values from at least 4 gels performed from different pull down experiments and perform the appropriate 
statistical tests. 
 
In-gel protein digestion with trypsin 
 
1.  Excise carefully pieces of gels including the spots to be processed, cut them in 1-mm large pieces and transfer them to 0.5 ml 
polypropylene tubes. Cut a control piece of gel from a blank region of the gel and process it in parallel with the samples. 
2.  Shrink the gel pieces by dehydration with acetonitrile for 10 min (in this step as in the following ones, use the minimal 
solution volume required to recover the gel pieces) and remove the liquid phase. 
3.  Swell the gel pieces by rehydration with 100 mM NH4HCO3 for 10 min. 
4.  Dehydrate the gel pieces with acetonitrile and remove the liquid phase. 
5.  Dry the gel pieces in a vacuum centrifuge for 5 min. 
6.  Swell the gel pieces with the digestion buffer (100 mM NH4HCO3, 5 mM CaCl2 and 150 ng trypsin per 2-100 ng protein spot) 
on ice for 45 min. 
7.  Add the same volume of the digestion buffer, but without trypsin, to keep the gel pieces wet during the digestion period (25°C, 
overnight). 
8.  Transfer the liquid phase to a 1.5 ml polypropylene tube. 
9.  Dehydrate the gel pieces with acetonitrile for 10 min and transfer the liquid phase to the same 1.5 ml tube. 
10.  Swell the gel pieces by rehydration with 100 mM NH4HCO3 for 10 min. 
11.  Dehydrate the gel pieces with acetonitrile for 10 min and transfer the liquid phase to the same 1.5 ml tube. 
12.  Renew 10 and 11. 
13.  Swell the gel pieces by rehydration with 5% formic acid for 10 min. 
14.  Dehydrate the gel pieces with acetonitrile for 10 min and transfer the liquid phase to the same 1.5 ml tube. 
15.  Renew 13 and 14. 
16.  Dry peptide samples with a vacuum centrifuge. 
 
Sample preparation for MALDI-TOF analysis 
 
1.  Dissolve the peptide mixture in 10 µl formic acid (2%). 
2.  Desalt the peptide mixture using Zip Tips C18 according to the manufacturer’s procedure. 
3.  Elute peptides with 10 µl of acetonitrile:trifluoroacetic acid (80:0.1%) and concentrate by evaporation to 2 µl. 
4. Mix  0.5  µl of analyte solution with the same volume of matrix (10 mg α-cyano-4-hydroxy-trans-cinnamic acid in 1 ml of 
acetonitrile:trifluoroacetic acid, 50:0.1%). 
5. Deposit  0.3  µl of this mixture on a stainless steel target. 
6.  Evaporate the solvent. 
7.  Introduce the target in the mass spectrometer. 
 
MALDI-TOF mass spectra interpretation and database interrogation 
 
1.  Calibrate the mass spectra using the auto-proteolysis products of trypsin (m/z 842.51, 1045.56, 2211.10) as internal calibrates 
using an appropriate software (e.g. the XTOF software, Bruker, etc.). 
2.  Select mono isotopic peptides in the mass range of 800-3500 Da. 
3.  Remove contaminating peptides from the mass list (peptides found in the control digestion performed on a blank region of the 
gel). 
4.  Search database with the resulting peptide mass list using an appropriate software (such as Mascot or Peptident). 
 
Micro purification of peptides for tandem mass spectrometry 
 
1. Suspend  2  µl of POROS R2 sorbent (PerSeptive Biosystems) in 50% methanol. 
2.  Load suspension in a capillary (Protana Inc.) using Gel loader tips. Bécamel et al.   104 
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3.  Centrifuge the capillary using the purification device. 
4.  Wash the micro column with 5 µl methanol:formic acid (50:5%) and store in 10 µl formic acid (5%). A new capillary with 
new POROS must be used for each analysis. 
5.  Dissolve peptide mixture in 5 µl formic acid (5%) and load onto the micro column. 
6.  Centrifuge the capillary using the purification device. 
7.  Wash the peptides on the column with 5 µl formic acid (5%). 
8.  Align a nano Electrospray (nanoES) capillary (ES380-ES382, Protana Inc) in continuation of the micro column. 
9.  Elute the peptides into the nanoES capillary twice with 0.5 µl methanol:formic acid (50:5%). 
10.  Place the nanoES capillary in the nanoES source head. 
 
Tandem mass spectra interpretation and database searching 
 
1.  Select double charged ions in the MS spectrum and fragment them by MS/MS. 
2.  Perform database search with the mass lists from MS/MS spectra of multiple peptides from the same protein using the Mascot 
software (http://www.matrixscience.com). 
3.  Combine the mass of the precursor peptide, the mass of the first peak of an identified sequence ladder, the sequence ladder and 
the final peak of the sequence ladder to obtain a peptide sequence tag (21). The ladder is obtained manually by starting from 
the highest m/z of a Y ion series of the MS/MS spectrum using an appropriate software (e.g. BioAnalyst, Applied 
Biosystems). 
4.  Perform database search with this tag using the PeptideSearch software (http://www.narrador.embl-heidelberg.de). 
5.  Compare results in 2 and 4. 